Dr. Robert Michael Sprague, DO

Dr. Sprague practices at HSHS St. Francis Hospital in Litchfield, Illinois, part of Hospital Sisters of St. Francis.

Dr. Sprague's NPI, 1255788022, was assigned on May 20, 2016. Dr. Sprague holds Illinois license 036156247.

Dr. Sprague's primary practice is HSHS St. Francis Hospital, at 1215 Franciscan Dr, Litchfield, IL 62056 in Montgomery County. The practice phone is (217) 324-2191.

Dr. Sprague's primary practice is HSHS St. Francis Hospital in Litchfield, Illinois, part of Hospital Sisters of St. Francis. Dr. Sprague is also affiliated with SIH Memorial Hospital of Carbondale. The medical group on file is CEP America. Dmand AI also links Dr. Sprague to 3 more hospitals and 7 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sprague practices, 5 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Sprague's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Sprague's licenses on file in 2 states: Illinois and Arizona.

CMS data shows 482 Medicare services from Dr. Sprague across 5 procedure codes in 2024, for 382 Medicare patients. Medicare paid $52,033 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 382 Medicare patients who saw Dr. Sprague in 2024. The largest group is 75 to 84, with 140 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sprague's median patient age at 52, with 60% women.

In 2024, Dr. Sprague wrote 231 Medicare Part D claims for 140 patients. 79% of them were for generic drugs. CMS names the drug for 146 of them, across 8 drugs with 11 or more claims each, at $7,704 in total drug cost. In 2023, CMS named 104 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Sprague for performance year 2024, reported as part of a group. Dr. Sprague accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Sprague from 3 drug and device companies from 2020 to 2023. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $42.